Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for urinary incontinence after prostatectomy for prostate cancer
2008-000968-16Phase 3Active
- Sponsor
- CeRePP
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in urinary incontinence (UI) comparing Duloxetine with Placebo (2 arms). Primary endpoints: Primary efficacy endpoint and Primary efficacy variable. Started Oct 2008; status: active.
02
Drugs
duloxetine
03
Conditions
urinary incontinence (UI)
Beyond the preview
Go deeper on 2008-000968-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000968-16.